Tesamorelin Drug Information

The Food and Drug Administration has licensed tesamorelin acetate (EgriftaTM) for the treatment of HIV-associated lipodystrophy. This condition is brought on by the medications used to treat HIV (human immunodeficiency virus) and causes an excessive amount of fat to be deposited around the abdomen (stomach). This medicine is injected subcutaneously in the stomach area once a day.
 
Prior to beginning treatment with tesamorelin, inform your healthcare provider about any other medical conditions you have or have a history of. People with a history of cancer or pituitary problems, for example, have a higher risk of problems with this medication and may not be able to take it.
 
(Click Tesamorelin for more information on this drug, including possible side effects, other important safety precautions, and more.)
 

Tesamorelin Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.